Atara Biotherapeutics, Inc. Services Agreements
10 Contracts & Agreements
- Amendment No. 10 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated May 31, 2024 (Filed With SEC on August 12, 2024)
- Amendment No. 9 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated April 30, 2024 (Filed With SEC on August 12, 2024)
- Amendment No. 8 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated March 31, 2024 (Filed With SEC on May 9, 2024)
- Amendment No. 7 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated January 31, 2024 (Filed With SEC on March 28, 2024)
- Amendment No. 6 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated December 30, 2023 (Filed With SEC on March 28, 2024)
- Amendment No. 5 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated September 27, 2023 (Filed With SEC on November 1, 2023)
- Amendment No. 3 to Commercial Manufacturing Services Agreement dated as of August 1, 2022 by and between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc (Filed With SEC on November 8, 2022)
- Amendment No. 2 to Commercial Manufacturing Services Agreement dated as of May 31, 2022 by and between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc (Filed With SEC on August 8, 2022)
- Amendment No. 1 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc., and Cognate BioServices Inc., dated September 1, 2021 (Filed With SEC on November 4, 2021)
- Commercial Manufacturing Services Agreement, by and between Atara Biotherapeutics, Inc. and Cognate BioServices, Inc., dated December 24, 2019 (Filed With SEC on February 27, 2020)
